We herein report two cases involving a mother and daughter who presented with clinical features of Cushing's syndrome (CS) at 50 and 29 years of age, respectively, and were both found to have adrenocorticotropic hormone-independent adrenal adenoma. Furthermore, a new adenoma was detected in the contralateral adrenal gland in the mother 10 years after surgical treatment, when she presented with subclinical CS. The pathogenesis of this disorder, including the presence of unknown genetic abnormalities causing hereditary CS, is currently poorly understood. In this report, we describe our experience with and consider the pathophysiological implications of two rare and very interesting cases of familial CS.
Introduction
Cushing's syndrome (CS) is characterized by pathologically by an elevated glucocorticoid level. Causes of CS in adults include Cushing's disease (pituitary-dependent bilateral adrenal hyperplasia), ectopic adrenocorticotropic hormone (ACTH) (and corticotropin-releasing hormone) production and primary adrenal disorders (adenoma, adrenocarcinoma and nodular hyperplasia). Familial forms of CS are rare (1) (2) (3) , and most reported cases have been associated with nodular adrenocortical dysplasia, which exhibits an autosomal dominant inheritance pattern. We herein report the cases of a mother and daughter who presented with clinical features of CS due to adrenal adenoma. Subsequently, an adrenal adenoma was detected in the contralateral adrenal gland in the mother 10 years after surgical treatment, when she presented with subclinical CS. To our knowledge, this is the first report to describe this rare form of familial CS. (Fig. 1) . Axial in-phase and outof-phase adrenal magnetic resonance imaging (MRI) scans showed an oval-shaped tumor in the left adrenal gland with signal dropout, a finding suggestive of intracellular lipids, a characteristic feature of benign adenoma (Fig. 2) . Adrenal scintigraphy using 131 I-labeled adosterol revealed a positive uptake in the left adrenal tumor with no uptake in the right adrenal gland (Fig. 3) . These findings indicated that the cortisol production in the adrenal tumor was not regulated by the hypothalamic-pituitary-adrenal axis.
Adrenal tumor
The patient underwent left laparoscopic adrenalectomy, during which the surface of the tumor was found to be smooth and not adherent to the kidney. On the pathological examination, the maximal diameter of the left adrenal tumor was 30×25 mm. The lesion was well-demarcated, solid and yellowish-brown in color. The histological sections revealed the nodular proliferation of cells in the zona fasciculata of the adrenal cortex. Neither nuclear atypia nor mitotic figures were detected. The stroma consisted of sinusoidal vessels ( Fig. 4) . Immunohistochemistry staining was positive for CYP11B1, 17α-hydroxylase and 3-βhydroxysteroid dehydrogenase (HSD) (Fig. 5 ). An adrenal cortical adenoma producing cortisol was considered to be the most likely diagnosis. The patient's clinical course was uneventful, and she was discharged on postoperative day 14. Hydrocortisone replacement therapy was continued for nine months after surgery. The administration of oral (75 g) glucose increased the patient's blood glucose and plasma insulin concentrations. In contrast, the oral administration of glucose induced no increases in the plasma cortisol level at that time (Table) .
Case 2
A 50-year-old woman, the mother of patient 1 (the family pedigree is shown in Fig. 6 ), was hospitalized for a further evaluation of a right adrenal incidentaloma measuring 30×25 mm in 2002. The physical examination findings were notable for a Cushingoid appearance, including central obesity, moon face, hirsutism and buffalo hump. The initial laboratory results included a serum potassium level of 4.0 mEq/L and a glucose level of 112 mg/dL. The serum cortisol level ranged from 21.3 to 27.2 μg/dL, without diurnal variation. The ACTH level was less than 2 pg/mL. A 24-hour urine collection specimen contained 345 μg/day of free cortisol, 9.8 mg/day of 17-ketosteroids and 22.9 mg/day of 17-OHCS. Dynamic testing showed no suppression of free cortisol with high-dose dexamethasone (24.6 μg/dL) (Table) . Abdominal CT scans showed a nodular mass in the right adrenal gland measuring 30×25 mm. The lesion was smooth, ovoid, well-defined, homogenous and exerted pressure on the inferior vena cava ( (Fig. 7) . Adrenal scintigraphy using 131 I-labeled adosterol revealed a positive uptake in the right adrenal tumor with no uptake in the left adrenal gland (Fig. 8) . Right adrenalectomy was performed.
The morphological findings indicated that the tumor was a demarcated round mass measuring 30×25 mm without capsule formation. Histological sections of the tumor demonstrated the proliferation of eosinophilic round tumor cells exhibiting a medullary growth pattern with mild lipofuscin deposition (Fig. 9) . Immunohistochemistry demonstrated positive staining of CYP11B1, 17α-hydroxylase and 3- 
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17 -hydroxylase 3-βHSD in the tumor, whereas the adjacent atrophic adrenal gland showed no immunoreactivity (Fig. 10 ). An adrenocortical adenoma producing cortisol, compact cell type, was considered to be the most likely diagnosis. Hydrocortisone replacement therapy was continued for eight months after surgery, and the patient was subsequently fol- 
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lowed up by her family doctor. After her daughter's surgery, i.e., 10 years after her adrenalectomy, a left adrenal incidentaloma measuring 18× 15 mm was detected on abdominal CT performed for dyspepsia, and the patient again consulted our hospital. She had no clinical signs or symptoms of hypercortisolism. An endocrine evaluation revealed (Table) the basal levels of plasma ACTH and cortisol to be normal (13.5 pg/mL and 13.9 μg/ dL, respectively). However, the nocturnal cortisol level was high (09:00 h, 13.9 μg/dL; 17:00 h, 7.6 μg/dL; 21:00 h, 8.3 μg/dL), and the plasma cortisol level was not completely suppressed by the overnight administration of 8 mg of dexamethasone (5.7 μg/dL). The urinary excretion of free cortisol (35.3 μg/day), urinary 11-OHCS (15.4 μg/day) and 17-KGS (5.78 mg/day) was normal. Other endocrine data were as follows: plasma aldosterone, 96.1 pg/mL; plasma renin activity (PRA), 0.4 ng/mL/h; plasma epinephrine, 9 pg/mL; plasma norepinephrine, 238 pg/mL; plasma dopamine, <5 pg/mL; urinary epinephrine, 3.7 μg/day; urinary norepinephrine, 183.5 μg/day; urinary metanephrine, 0.04 mg/day; urinary normetanephrine, 0.22 mg/day; urinary vanillylmandelic acid, 3.1 mg/day; and urinary homovanillic acid, 3.4 mg/day. The administration of oral (75 g) glucose induced increases in the blood glucose and plasma insulin levels; however, the plasma cortisol level did not increase significantly following the administration of glucose. Abdominal CT scans revealed a nodular mass in the left adrenal gland measuring 18×15 mm (Fig. 11) . The lesion was hypodense, homogenous and exhibited rapid enhancement following the injection of intravenous contrast medium. Axial in-phase and 
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-hydroxylase 3- Figure 11 . Abdominal CT scan shows a nodular mass in the left adrenal gland measuring 18×15 mm. The mass was hypodense, homogenous, and showed rapid enhancement after intravenous contrast medium injection. 
Adrenal tumor

IN OUT
out-of-phase MR images showed the mass to display classic signal dropout (Fig. 12 ). These findings indicated that the tumor was an adenoma associated with subtle abnormalities of the hypothalamic-pituitary-adrenal axis. Since the patient had only one adrenal gland and there were no remarkable signs or symptoms of CS, she was closely followed without intervention.
Discussion
The initial step in the differential diagnosis of CS is to distinguish ACTH-dependent from ACTH-independent forms of hypercortisolism. ACTH dependency accounts for 80% of cases of CS. Of these cases, 85% involve ACTH-secreting pituitary adenomas, while 15% involve ectopic ACTHsecreting tumors (4). ACTH-independent hypercortisolism is always of adrenocortical origin. By far the most common cause (>95% of cases) is adrenocortical adenoma or carcinoma. Most remaining patients have primary pigmented nodular adrenal dysplasia (PPNAD), a syndrome characterized by the presence of multiple small bilateral pigmented adrenocortical nodules, often in association with the Carney complex (5, 6). The Carney complex presents in adolescence or young adulthood in patients with unusual conditions, such as myxomas with spotty skin pigmentation, endocrine overactivity or schwannomas. The adrenal glands in patients with this disorder are often small or normal in size with multiple black and brown nodules associated with intranodular cortical atrophy. An even rarer form of ACTHindependent primary adrenal hypercortisolism consists of multiple bilateral adrenocortical macronodules inducing the striking enlargement of the adrenal glands, called ACTHindependent macronodular adrenocortical hyperplasia (AIMAH) (7) (8) (9) (10) (11) . The histological features of adrenal glands with AIMAH include multiple large nodules with interspersed markedly hyperplastic adrenal tissue between the nodules; there is no pigmentation.
The present patients, a mother and daughter, had ACTHindependent forms of hypercortisolism with single adrenal tumors on CT or MRI in addition to unilateral uptake on adrenal scintigraphy. Histologically, the excised adrenal tumors were very similar, and both were adrenal adenomas. The tumor features in the mother and daughter included a compact cell type and demarcated round masses without capsule formation. Immunohistochemistry demonstrated that both adenomas produced cortisol.
Most often Cushing's disease occurs as a sporadic, isolated condition. Rarely, it can appear as a component of genetic syndromes, such as multiple endocrine neoplasia type 1 (MEN1), Carney complex (CNC) and micronodular adrenal disease. MEN1 is a familial disorder that exhibits autosomal-dominant transmission due to an inactivating mutation in the MEN1 gene located in chromosome 11q13. Most adrenal tumors in patients with MEN1 are nonfunctional; however, a few cortisol-producing tumors have been reported (12) . In the present cases, neither the daughter nor her mother had MEN1-related endocrine disorders, including hyperparathyroidism, the most frequently observed endocrine disorder in MEN1 patients. CNC is another genetic disorder that can cause Cushing's syndrome. Inactivating germline mutations in the gene coding for PRKAR1A, a regulatory subunit of PKA, have been found (13, 14) . The gene coding for PRKAR1A is located on chromosome 17q22-23. All described mutations (small or large deletions, base substitutions, etc.) usually result in premature stop codons. It has been noted that such mutations can also induce the expression of abnormal proteins, thus demonstrating that alteration of the PRKAR1A function augments the PKA activity, thereby leading to tumorigenesis in tissues affected by CNC. More than 60% of CNC patients harbor pathogenic PRKAR1A mutations. Other loci located on chromosome 2 (2p16, 2q31.2 regions) have been implicated in the tumorigenesis of CNC. Inactivating mutations in the phosphodiesterase11A (PDE11A) gene, located on chromosome 2q31.2, have been described in patients with PPNAD negative for PRKAR1A mutations (15) . Inactivating mutations in PDE11A result in the disruption of the ability to hydrolyze cAMP and cGMP. For example, a mutation in the gene coding for PDE8B (locus 5q13) resulting in a disrupted ability to hydrolyze cAMP has been described (16) . The gross and histological appearance of PPNAD is characteristic. The pathological findings of the present cases did not involve PPNAD characteristics, and we did not detect any other CNC-related disorders, such as skin pigmentation or cardiac myxoma. Based on these clinical and pathological observations, we concluded that genetic alterations of these known genes were unlikely to be present in these cases. Therefore, we did not perform any genetic testing.
Other genetic mutations responsible for several primary cortical disorders have been identified (17) . A somatic mutation of TP53, a tumor suppressor gene (18) , and a germline mutation of the adenomatous polyposis coli (APC) gene that result in the activation of the Wnt/β-catenin signaling pathway also play important roles in cell proliferation and have been demonstrated in patients with adrenocortical tumors (19) . Recently, aldosterone-producing adenoma (APA) was shown to possess somatic mutations (G151R and L168R) in KCNJ5 that cause alterations in channel selectivity leading to nonselective Na entry and chronic depolarization (20) .
In addition, several hypotheses have been proposed in the literature (17, 21, 22) , including the presence of unknown non-ACTH adrenal growth factors or the expression of ectopic receptors for such substances, such as increased responsiveness to gastric inhibitory polypeptide receptors (food-dependent hypercortisolism), vasopressin receptors or β-adrenergic receptors and so on, that do not usually control the adrenal growth or function. Even if the plasma cortisol concentration did not increase significantly following the administration of oral glucose in either the mother or daughter, the examinations conducted after the removal of the adrenal adenomas detected overt Cushing's syndrome. The possibility that these pathological mechanisms may have played a role in the present cases cannot be completely excluded. As far as we were able to investigate, there were no endocrine disorders in relatives or consanguineous marriage, although the existence of an asymptomatic endocrine disease also cannot be completely excluded (Fig. 1) . Therefore, the pathogenesis underlying these familial cases remains unclear, although the presence of unknown genetic abnormalities causing hereditary CS is suggested. Further genetic analyses of such familial cases are required.
In the literature, reported bilateral adrenocortical adenomas have usually been found simultaneously. However, in the present case 2, the right and left adrenocortical adenomas inducing the excess production of cortisol developed 10 years apart. Tung et al. (23) also reported bilateral adrenocortical adenomas causing ACTH-independent CS diagnosed nine years apart. Imai et al. (24) reported the results of long-term follow-up studies after adrenalectomy in 122 patients with CS. Of 70 patients with adrenocortical adenoma, CS recurred in two (2.9%) cases due to the development of contralateral adrenocortical adenomas 20 years after the first adrenalectomy. These findings highlight the importance of providing regular follow-up in patients treated with unilateral adrenalectomy for adrenocortical adenoma.
To our knowledge, the present cases are the first reported familial cases of CS caused by adrenal adenoma. Furthermore, a second adrenocortical adenoma producing excess cortisol developed 10 years after the first lesion in the mother. Although the pathogenesis underlying these cases is currently poorly understood, further study is warranted, and close follow-up of both patients is required, focusing particularly on the possibility of tumor development in the other adrenal gland in the daughter and the presence of the clinical features of CS in the mother.
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